Jazmín Díaz-Regañón

Activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: The SUPERIOR multicentre study

Sergio García‐Fernández, María García-Castillo, Germán Bou et al. · International Journal of Antimicrobial Agents · 2019 · 48 citations

Life Sciences, Infectious Diseases, Microbiology +10

Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain

María García-Castillo, Sergio García‐Fernández, Rosa Gómez-Gil et al. · International Journal of Antimicrobial Agents · 2018 · 37 citations

Life Sciences, Infectious Diseases, Microbiology +16

Monitoring the antimicrobial susceptibility of Gram-negative organisms involved in intraabdominal and urinary tract infections recovered during the SMART study (Spain, 2016 and 2017).

Rafael Cantón, Elena Loza, Javier Aznar et al. · PubMed · 2019 · 33 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Risk Factors and Outcomes for Multidrug Resistant Pseudomonas aeruginosa Infection in Immunocompromised Patients

Pilar Hernández-Jiménez, Francisco López‐Medrano, Mario Fernández‐Ruiz et al. · Antibiotics · 2022 · 33 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in<i>Pseudomonas aeruginosa</i>isolates recovered from ICU patients in Spain and Portugal depicted by WGS

Marta Hernández-García, María García-Castillo, Sergio García‐Fernández et al. · Journal of Antimicrobial Chemotherapy · 2020 · 29 citations · Full text

Veterinary Medicine, Infectious Diseases, Antimicrobial Resistance +16